The FDA has just approved the very first prescription medication to improve eyelash length and fullness! LATISSE (bimatoprost ophthalmic solution) 0.03% is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.

Introductory Price: $120 per kit
Save an additional $20 when purchased with BOTOX® or Juvederm™ injection the same day.
Expires 3/31/09.

See the results and learn more at www.latisse.com

Posted in: Latisse